All physicians should be prepared to manage dyspnea, especially during the coronavirus disease 2019 pandemic.[1][1] Dyspnea, a subjective experience of uncomfortable breathlessness, can usually be ...

Nonpharmacologic Interventions in the Management of Dyspnea In addition to pharmacologic interventions and oxygen, there are a number of nonpharmacologic strategies that can be beneficial in the ...

More than 90% of patients with advanced COPD experience dyspnea. A daily morphine dose of <30 mg daily is safe for treating refractory breathlessness.

Dyspnea, whether of cardiac origin or due to exertion by a normal person, was formerly described as resulting from the accumulation in the blood of carbon dioxide, formed by the combination of ...

(HealthDay News) — The majority of hospitalists believe that routinely assessing dyspnea severity would enhance their clinical decision making and positively affect patient care, according to a ...

If dyspnea is causing anxiety (or vice versa), limiting the number of visitors in the patient’s room and playing soft music can help create a calm environment.

B-type natriuretic peptide levels are higher in patients with congestive heart failure than in patients with dyspnea from other causes. We conducted a prospective, randomized, controlled study of 4 ...

The majority of hospitalists agree that routine dyspnea severity assessment would improve patient care.

HIIT was more effective at reducing dyspnea levels and lower limb fatigue and increasing physical activity levels (PAL) compared with constant-load exercise (CLE), researchers found.

Pharmacologic Interventions for Dyspnea Management The APN possesses the advanced clinical knowledge and skills to be able to synthesize the assessment information and create a comprehensive plan ...